Around 50 million people worldwide suffer from epilepsy, making it one of the most common neurological diseases. To decrease this figure and pave the way for future ground-breaking epilepsy research, seven large EU-funded projects joined forces in May 2018 in Brussels, Belgium, in a unique community-building event – the epiXchange conference. Designed to gather a critical mass of epilepsy researchers and stakeholders, the conference became a forum for exchange and discussions on latest research results and future research policies.

The epiXchange cluster has now published an article in Epilepsia, presenting major achievements by the cluster in the areas of biomarkers, genetics, therapeutics, comorbidities and biobanks as well as recommendations for future research to develop and bring novel solutions to the patients. To read the article, click here.

More information about the epiXchange event can be found here.